Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products and technologies. The Company develops, manufactures and commercialize, for itself or with partners, therapeutic products using its drug delivery systems. The Company products include XYOSTED, OTREXUP, NOCDURNA, Epinephrine Injection USP, Sumatriptan Injection USP, Makena and Teriparatide Injection. Its XYOSTED injection product for subcutaneous administration of testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Its OTREXUP is a subcutaneous methotrexate injection is a disposable auto injector, indicated for adults with severe active rheumatoid arthritis (RA), children with active polyarticular juvenile idiopathic arthritis and adults with severe recalcitrant psoriasis.